Leflunomide-induced peripheral neuropathy: Rapid resolution with cholestyramine wash-out [3]

Rheumatology

Volumn 43, Issue 6, 2004, Pages 809-

  Hill, Catherine L ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COLESTYRAMINE; LEFLUNOMIDE; METHOTREXATE; OMEPRAZOLE; ROFECOXIB; SALAZOSULFAPYRIDINE; TERIFLUNOMIDE;

ADULT; CASE REPORT; DISEASE COURSE; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HUMAN; LETTER; NERVE CONDUCTION; NEUROLOGIC DISEASE; PARESTHESIA; PERIPHERAL NEUROPATHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; STEADY STATE; SYMPTOMATOLOGY;

EID: 3042682270     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh150     Document Type: Letter

References (3)

1. Carulli MT, Davies UM. Peripheral neuropathy: an unwanted effect of leflunomide? Rheumatology 2002;41:952-3.
2. Rozman B. Clinical pharmacokinetics of leflunomide. Clin Pharmacokinet 2002;41:421-30.
3. Aventis Pharmaceuticals. Arava (leflunomide) drug prescribing information. Available at www.arava.com